Surge in Open Interest Signals Increased Trading Activity for Sun Pharmaceutical Industries
2025-04-03 15:00:19Sun Pharmaceutical Industries Ltd (SUNPHARMA) has experienced a significant increase in open interest today, reflecting heightened activity in the stock. The latest open interest stands at 79,456 contracts, up from the previous 62,143, marking a change of 17,313 contracts or an impressive 27.86% increase. The trading volume for the day reached 125,480 contracts, indicating robust market engagement. In terms of price performance, Sun Pharma has outperformed its sector by 0.96%, with the stock gaining 3.88% over the last two days. Today, it opened with a gain of 2.41% and reached an intraday high of Rs 1,812.7, reflecting a rise of 5.78%. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong upward trend. The pharmaceuticals and drugs sector has also seen a gain of 2.15%, contributing to the overall positive sentiment. Notably, the delivery...
Read MoreSun Pharmaceutical Industries Ltd Sees Surge in Call Options with 30,312 Contracts Traded
2025-04-03 15:00:06Sun Pharmaceutical Industries Ltd has emerged as one of the most active stocks in the market today, particularly in the options segment. The company, a key player in the Pharmaceuticals & Drugs industry, has seen significant trading activity in call options with expiry dates set for April 24, 2025. Notably, the call option with a strike price of Rs 1820 recorded 11,492 contracts traded, generating a turnover of approximately Rs 1,010.38 lakhs, while the Rs 1800 strike price option saw 18,820 contracts traded with a turnover of around Rs 2,314.19 lakhs. The underlying value of Sun Pharma is currently at Rs 1770.0, reflecting a strong market position with an open interest of 2,999 for the Rs 1820 strike and 3,287 for the Rs 1800 strike. Performance metrics indicate that the stock has outperformed its sector by 1.11%, gaining 4.03% over the last two days. Today, it opened with a gap up of 2.41% and reached a...
Read MoreSurge in Open Interest Signals Increased Activity for Sun Pharmaceutical Industries
2025-04-03 14:00:22Sun Pharmaceutical Industries Ltd (SUNPHARMA) has experienced a significant increase in open interest today, reflecting heightened activity in the stock. The latest open interest stands at 79,456 contracts, up from the previous figure of 62,143, marking a change of 17,313 contracts or a 27.86% increase. The trading volume for the day reached 125,480 contracts, indicating robust participation in the market. In terms of price performance, Sun Pharma has outperformed its sector by 1.33%, with the stock gaining 4.48% over the last two days. Today, it opened with a gain of 2.41% and reached an intraday high of Rs 1,812.7, reflecting a rise of 5.78%. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong upward trend. The pharmaceuticals and drugs sector has also seen a gain of 2.22%, while Sun Pharma's delivery volume on April 2 has increased b...
Read MoreSun Pharmaceutical Sees Surge in Open Interest Amid Increased Trading Activity
2025-04-03 12:00:19Sun Pharmaceutical Industries Ltd (symbol: SUNPHARMA) has experienced a significant increase in open interest today, reflecting heightened activity in its trading. The latest open interest stands at 78,979 contracts, up from the previous figure of 62,143, marking a change of 16,836 contracts or a 27.09% increase. The trading volume for the day reached 109,569 contracts, indicating robust market engagement. In terms of price performance, Sun Pharma has outperformed its sector by 1.84%, with the stock gaining 5.27% over the past two days. Today, it opened with a gain of 2.41% and reached an intraday high of Rs 1,812.7, reflecting a 5.78% increase. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong upward trend. The pharmaceuticals and drugs sector overall has seen a gain of 2.51%. Additionally, the delivery volume on April 2 was recorded...
Read MoreSun Pharmaceutical Sees Surge in Open Interest Amid Increased Market Activity
2025-04-03 11:00:10Sun Pharmaceutical Industries Ltd (SUNPHARMA) has experienced a significant increase in open interest today, reflecting heightened activity in the stock. The latest open interest stands at 69,890 contracts, up from the previous figure of 62,143, marking a change of 7,747 contracts or a 12.47% increase. The trading volume for the day reached 62,053 contracts, indicating robust participation in the market. In terms of price performance, Sun Pharma has outperformed its sector by 1.38%, with the stock gaining 4.78% over the last two days. Today, it opened with a gain of 2.41% and reached an intraday high of Rs 1,812.7, reflecting a rise of 5.78%. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong upward trend. The pharmaceuticals and drugs sector has also seen a gain of 2.35%, contributing to the overall positive sentiment. Notably, the de...
Read MoreSun Pharmaceutical Shows Strong Trading Volume Amid Sector Growth and Investor Interest
2025-04-03 10:00:15Sun Pharmaceutical Industries Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has shown significant activity in today's trading session. The stock, trading under the symbol SUNPHARMA, recorded a total traded volume of 3,369,436 shares, with a total traded value of approximately Rs 57.57 crore. Opening at Rs 1,695.00, the stock experienced a notable gain of 2.41% and reached an intraday high of Rs 1,718.45, reflecting a robust performance that outpaced its sector by 1.65%. Over the past two days, Sun Pharma has demonstrated a consecutive gain, accumulating a total return of 6.51%. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend. Additionally, the delivery volume on April 2 has surged to 2.61 lakh shares, marking a 54.45% increase compared to the 5-day average delivery volume, suggesting rising investor p...
Read MoreSun Pharmaceutical Sees Surge in Open Interest Amid Increased Trading Activity
2025-04-03 10:00:09Sun Pharmaceutical Industries Ltd (symbol: SUNPHARMA) has experienced a significant increase in open interest today, reflecting heightened trading activity. The latest open interest stands at 69,890 contracts, up from the previous 62,143, marking a change of 7,747 contracts or a 12.47% increase. The trading volume for the day reached 62,053 contracts, indicating robust market engagement. In terms of price performance, Sun Pharma has outperformed its sector by 1.28%, with the stock gaining 6.14% over the last two days. Today, it opened with a gain of 2.41% and reached an intraday high of Rs 1,811.95, reflecting a 5.74% increase. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong upward trend. The pharmaceuticals and drugs sector has also shown positive momentum, gaining 3.59% today. Notably, the delivery volume on April 2 was 26.1 lakh ...
Read More
Sun Pharmaceutical Industries Shows Strong Performance Amid Market Volatility
2025-04-03 09:30:38Sun Pharmaceutical Industries has shown notable performance, gaining 4.77% on April 3, 2025, and outperforming its sector. The stock has experienced consecutive gains over two days, high volatility, and is trading above multiple moving averages, indicating a strong performance trend amid a fluctuating broader market.
Read More
Sun Pharmaceutical Adjusts Valuation Amid Mixed Financial Indicators and Growth Trends
2025-04-03 08:12:29Sun Pharmaceutical Industries has recently experienced an evaluation adjustment, reflecting changes in its financial metrics and market position. The company continues to show consistent growth, with net sales and operating profit increasing significantly, while maintaining a solid performance in profitability despite a shift in valuation.
Read MoreAnnouncement under Regulation 30 (LODR)-Press Release / Media Release
07-Apr-2025 | Source : BSESun Pharma introduces a novel class of drug Fexuclue (Fexuprazan) in India.
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
02-Apr-2025 | Source : BSEThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on April 01 2025 for Raksha Sudhir Valia
Announcement under Regulation 30 (LODR)-Change in Directorate
31-Mar-2025 | Source : BSEChange in Board of Directors and Audit Committee
Corporate Actions
No Upcoming Board Meetings
Sun Pharmaceutical Industries Ltd has declared 1050% dividend, ex-date: 06 Feb 25
Sun Pharmaceutical Industries Ltd has announced 1:5 stock split, ex-date: 25 Nov 10
Sun Pharmaceutical Industries Ltd has announced 1:1 bonus issue, ex-date: 29 Jul 13
No Rights history available